(Q41521259)

2 October 2017

1 reference

title

The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections (English)

1 reference

Mycobacterium avium avium

2 October 2017

main subject

1 reference

Amsden GW

1

1 reference

2 October 2017

Peloquin CA

series ordinal

2

1 reference

2 October 2017

Berning SE

series ordinal

3

1 reference

2 October 2017

publication date

1 July 1997

1 reference

2 October 2017

1 reference

2 October 2017

volume

54

1 reference

2 October 2017

issue

1

1 reference

2 October 2017

page(s)

69-80

1 reference

Susceptibility testing of Mycobacterium avium complex isolates

2 October 2017

cites work

1 reference

12 December 2020

Mycobacterium avium strains resistant to clarithromycin and azithromycin

1 reference

12 December 2020

Rifabutin-associated uveitis

1 reference

12 December 2020

Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions

1 reference

12 December 2020

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450

1 reference

12 December 2020

Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease

1 reference

12 December 2020

Medical management of AIDS patients. Tuberculosis and nontuberculous mycobacterial disease

1 reference

12 December 2020

A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome

1 reference

12 December 2020

The Mycobacterium avium complex

1 reference

12 December 2020

Pharmacokinetics of clarithromycin and zidovudine in patients with AIDS.

1 reference

12 December 2020

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team

1 reference

12 December 2020

Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex

1 reference

12 December 2020

Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774.

1 reference

12 December 2020

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

1 reference

12 December 2020

Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS.

1 reference

12 December 2020

Advances in the prevention and treatment of Mycobacterium avium disease.

1 reference

12 December 2020

Azithromycin: the first azalide antibiotic

1 reference

12 December 2020

In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex

1 reference

12 December 2020

Controversies in the management of Mycobacterium avium complex infection in AIDS patients

1 reference

12 December 2020

Opportunistic pathogens in the genus Mycobacterium

1 reference

12 December 2020

Therapeutic drug monitoring of the antimycobacterial drugs.

1 reference

12 December 2020

Mycobacterium avium complex infection and AIDS: advances in theory and practice

1 reference

12 December 2020

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

1 reference

12 December 2020

Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex

1 reference

12 December 2020

Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium

1 reference

12 December 2020

Disease due to Mycobacterium avium-intracellulare

1 reference

12 December 2020

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group

1 reference

12 December 2020

Mechanism of Antibiotic Resistance inMycobacterium intracellulare

1 reference

12 December 2020

Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution

1 reference

12 December 2020

The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin

1 reference

12 December 2020

A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions

1 reference

12 December 2020

Macrolides versus azalides: a drug interaction update

1 reference

12 December 2020

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

1 reference

12 December 2020

A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study G

1 reference

12 December 2020

Effects of antimicrobial agents on survival of Mycobacterium avium complex inside alveolar macrophages obtained from patients with human immunodeficiency virus infection

1 reference

12 December 2020

In-vitro activity of quinolones and macrolides against mycobacteria.

1 reference

12 December 2020

[Clinical pharmacokinetics of azithromycin]

1 reference

12 December 2020

Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.

1 reference

12 December 2020

Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial

1 reference

12 December 2020

Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications

1 reference

12 December 2020

Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS

1 reference

12 December 2020

Accumulation of clarithromycin in macrophages infected with Mycobacterium avium

1 reference

12 December 2020

10.2165/00003495-199754010-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

2 October 2017

1007369939

0 references

1 reference